by AIP Online Bureau | Aug 15, 2024 | Eco/Invest/Demography, Health, International News, Non-Life, Policy, Regulation, Reinsurance
Biden’s signature Inflation Reduction Act, signed into law in 2022, was the first to allow Medicare to negotiate prices for some of the most costly drugs that the program covers for 66 million people. The new prices will go into effect in 2026 LARGO,...
by AIP Online Bureau | Nov 21, 2021 | Eco/Invest/Demography, Health, International News, Non-Life, Policy, Regulation
Polls show that Americans across the political spectrum overwhelmingly favor government action to reduce drug prices. The chief cost complaints are: high out-of-pocket costs for patients, high and rising list prices, and high launch prices for new medicines. The Biden...
